Genetic Predisposition to Disease
70
20
25
27
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 70 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
11%
3 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 27 completed trials
Clinical Trials (70)
Return of Genomic Results and Aggregate Penetrance in Population-Based Cohorts
Effects of Sirolimus on Asymptomatic ApoE4 Carriers
VIGOR: Virtual Genome Center for Infant Health
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Application of a Systematic Developmental Assessment to a Novel Population: Infants With Rare Genetic Disorders
TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ Failure
Expression of Genes Relating Hypertension and Efficacy of 4-7-8 Breathing Control on Reducing Blood Pressure
Full-scale Intervention Study: Genetic Risk Communication and Wearables
Germline Testing for Predisposition to Myeloid Malignancies
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
Helix Research Network
Microbiome and Association With Implant Infections
The China Neonatal Genomes Project
This Study Consists of Two Study Parts Conducted Under a Single IRB. Part I: Short Term ApoE-dependent Cerebral Blood Flow Response to Sirolimus in Cognitively Normal Adults Part II: Short Term ApoE-dependent Cerebral Blood Flow and Lung Perfusion Response to Sirolimus in Cognitively Normal Adults
Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants
Assesment of Multiomics Profiles in Health and Disease.
Healthy Volunteers Study
Blood Markers of Early Pancreas Cancer
Genetic Predisposition to High Blood Pressure
Breast Cancer Risk After Diagnostic Gene Sequencing